The IL-17A/IL-17RA axis in pulmonary defence and immunopathology

Research output: Contribution to journalShort surveypeer-review


The interleukin (IL)-17A/IL-17 receptor A (IL-17RA) axis is emerging as a key player in host defence. Several studies have demonstrated that IL-17A-mediated responses play a critical role in both acute and chronic inflammation induced by infectious agents, environmental stimuli and genetic diseases in the airways. In this regard, it is becoming evident that IL-17A/IL-17RA signalling may have a protective and beneficial impact on health, but that it can also result in detrimental outcomes. On one hand, the IL-17A/IL-17RA axis can contribute to the elimination of noxious stimuli and to the resolution of acute inflammatory processes; on the other hand, it can exacerbate immunopathological responses, contributing to the development and progression of chronic respiratory illnesses. In addition, cellular and molecular signatures underlying IL-17A/IL-17RA signalling have been increasingly identified, although further studies are needed to clarify such complex responses. Here, we discuss the latest discoveries on the role of the IL-17A/IL-17RA axis in driving host pulmonary defence and immunopathology.

Original languageEnglish
Pages (from-to)19-27
Number of pages9
JournalCytokine and Growth Factor Reviews
Publication statusPublished - Aug 1 2016


  • Host defence
  • Immunopathology
  • Interleukin (IL)-17 receptor A
  • Interleukin (IL)-17A

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'The IL-17A/IL-17RA axis in pulmonary defence and immunopathology'. Together they form a unique fingerprint.

Cite this